Congress Reviews

During the Specialized Working Group session, ‘Quality of Life and Symptoms: Promoting Connection Between Patients and Clinicians’, which…

The most important advances in Ph-negative ALL come from the incorporation of immunotherapy into first-line ALL. In this sense…

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…

THIS SUMMER, the welcoming city of Glasgow, UK, proudly hosted the EAACI Congress 2025, a pivotal event that brought together…

THE EUROPEAN Alliance of Associations for Rheumatology (EULAR) 2025 Congress, the most dynamic event of the year for the rheumatology…

CHRONIC spontaneous urticaria (CSU) was a key focus at the EAACI Congress 2025 in Glasgow, UK, reflecting a growing momentum in the search…